Gastrointestinal Cancers

The FDA has approved Hercessi for the adjuvant treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

Research has shown aspirin use to be associated with lower rates of metastasis for some patients.

At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying cancer-free.

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

After treatment for colorectal cancer, I wrote this poem to my children because I wasn't sure how much time I had left.

There was not a significant difference between presurgical and postsurgical chemotherapy in patients with locally advanced colon cancer, researchers found.

SKB264 led to durable responses and a manageable safety profile in patients with gastric or gastroesophageal junction cancers, an expert said.

I've found that nutrition and healthy foods play an important role during cancer.

There is no difference in recovery, complication or cost between the two most common surgical approaches for esophageal cancer.

CAN-2409 has been associated with improved survival among patients with non-metastatic, borderline resectable pancreatic ductal adenocarcinoma.

The novel treatment, zanidatamab, has been submitted to the FDA via a Biologics License Application for patients with HER2-positive biliary tract cancer.

After five years of being cancer-free, my oncologist said I'm graduated and can live my life freely.

Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors.

When I was my husband's caregiver, I tried to make things comfortable, but I'm not sure if the drugs and bedpans could ever make it right.

The GI cancer space has “made huge strides” in recent years, which opened more options for patients with a type of esophageal cancer, an expert said.

Here are four signs of your doctor not listening and four things I do when they don't listen to me.

Certain oral chemotherapies may cause hand-foot syndrome, but reducing the dose of the drug allows it to heal, an expert told CURE®.

Moderate multivitamin use was associated with a decreased risk of death in patients with colorectal cancer, though more research is needed, an expert said.

The Food and Drug Administration approved Tevimbra for pretreated metastatic or unresectable esophageal squamous cell carcinoma.

Although many hate drinking the prep for colonoscopies, I view it as a privilege.

From TikTok singer Cat Janice dying of cancer to Taylor Swift giving a 9-year-old with brain cancer the “22” hat during a recent concert, here is what’s happening in the oncology space this week.

The Food and Drug Administration has accepted a Biologics License Application for Tevimbra with chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

After I was diagnosed with colon cancer, I learned to take care of myself more and be more outspoken than ever before.

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.

Spending a fourth of my life as a cancer survivor, I’ve learned a few lessons along the way.

I wondered how much I could contribute to cholangiocarcinoma awareness, but determined that if I help just one person, then that's a success.

The Food and Drug Administration has approved Onivyde with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma, the agency has announced.